These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9199010)

  • 21. Assessment of the usefulness of antithrombin-III in the management of disseminated intravascular coagulation in obstetrically Ill patients.
    Kobayashi A; Matsuda Y; Mitani M; Makino Y; Ohta H
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):688-93. PubMed ID: 19833617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
    Iba T; Thachil J
    Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
    [No Abstract]   [Full Text] [Related]  

  • 24. [Substitution of antithrombin III in shock patients].
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antithrombin III in intensive therapy].
    Baudo F; Caimi TM; Decataldo F; Calori G
    Minerva Anestesiol; 1999; 65(1-2 Suppl 1):71-6. PubMed ID: 10206028
    [No Abstract]   [Full Text] [Related]  

  • 26. Disseminated intravascular coagulation in cancer patients.
    Levi M
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):129-36. PubMed ID: 19285279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epilogue: disseminated intravascular coagulation and antithrombin III in intensive care medicine: pathophysiological insights and therapeutic hopes.
    Schuster HP
    Semin Thromb Hemost; 1998; 24(1):81-3. PubMed ID: 9515783
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic intervention in disseminated intravascular coagulation: have we made any progress in the last millennium?
    Levi M; de Jonge E; van der Poll T
    Blood Rev; 2002 Dec; 16 Suppl 1():S29-34. PubMed ID: 12918785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
    Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
    Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
    Kobayashi H; Kawai S; Oshitani H; Tamakuma S; Hayasaka H; Akiyama M; Nakamura T; Hashimoto I; Sawada Y; Takebe K
    Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of disseminated intravascular coagulation (DIC)].
    Matsuda T
    Nihon Rinsho; 1978 May; Suppl():1682-3. PubMed ID: 691480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Substitution therapy using antithrombin III concentrate].
    Thaler E; Lechner K
    Dtsch Med Wochenschr; 1982 Jan; 107(4):147-9. PubMed ID: 7056170
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical use of antithrombin III concentrates.
    Vinazzer H
    Vox Sang; 1987; 53(4):193-8. PubMed ID: 3326267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy with antithrombin III in burned children--pilot study].
    Del Principe D; Pietrantoni R; Menichelli A; Siviero MC; Luzi F; Colucci C; Orsini D
    Haematologica; 1990; 75 Suppl 2():33-40. PubMed ID: 2387549
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal diseases, disseminated intravascular coagulation, and antithrombin III.
    Brandt P; Jespersen J
    Nephron; 1983; 34(3):203-4. PubMed ID: 6877453
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: an update.
    Franchini M
    Clin Lab; 2005; 51(11-12):633-9. PubMed ID: 16329621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of antithrombin III concentrates in disseminated intravascular coagulation].
    Aoki N; Matsuki K; Sakata Y
    Rinsho Ketsueki; 1982 Jun; 23(6):804-10. PubMed ID: 7176087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.